Talk:RTI Surgical

Proposed Updates
I am the Corporate Archivist at RTI Surgical and propose the following updates and clarifications to be made on our behalf to correct inaccuracies. This is my first time engaging on Wikipedia. Any assistance is welcome.

RTI Surgical Company Overview RTI Surgical is a global surgical implant company that designs, develops, manufactures and distributes biologic, metal and synthetic implants. The company’s current focus is on investing in differentiated products and building scale in Spine and becoming a world-class private label OEM partner. RTI’s implants are used in spine, orthopedic, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.

RTI Surgical manufactures metal and synthetic implants and process donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using their proprietary BIOCLEANSE®, TUTOPLAST® and CANCELLE® SP sterilization processes. RTI processes tissue at facilities in Alachua, Florida, and Neunkirchen, Germany, and manufactures metal and synthetic implants in Marquette, Michigan and Greenville, North Carolina. They are a member of AdvaMed and accredited in the U.S. by the American Association of Tissue Banks. RTI Surgical implants are distributed directly to hospitals throughout the U.S. and in more than 50 countries worldwide with the support of both in-house and third-party representatives as well as through larger purchasing companies. RTI Surgical is a publicly traded company and is listed on Nasdaq under the symbol RTIX.

RTI Surgical’s spine portfolio includes hardware, interbody and orthobiologic products, including coflex, SImmetry, Fortilink IBF System with TETRAfuse and ViBone. Conditions that RTI Surgical products help treat range from lumbar spinal stenosis and sacroiliac joint pain to degenerative disc disease and a broad range of spinal disorders.

History In January 1969, The Tutoplast Tissue Sterilization Process was developed to sterilize and preserve tissue for implantation. The Tutoplast Process inactivates pathogens and removes bacteria, and the low dose gamma irradiation ensures sterility of the final packaged product.

In May 1992, Dr. Matthew Songer, an orthopedic surgeon, founded Pioneer in 1992 in Marquette, MI. Songer was not satisfied with the spinal cables on the market, which encouraged him to develop his own, a product we still distribute, called the Songer® Spinal Cable.

In October 1992, Tutogen Medical (Tutogen) formed and built its headquarters in Neunkirchen am Brand, Germany. Tutogen manufactured safe, high-quality xenograft and allograft implants for use in surgeries around the globe.

In January 1998, Tutogen expanded to the United States by moving its corporate headquarters to Progress Park in Alachua, Fla.

In February 1998, the University of Florida Tissue Bank transferred its allograft processing operations, related equipment and technologies, distribution arrangements, and research and development activities to Regeneration Technologies. This spin off from the University of Florida (UF) is one of the most successful UF technology transfers to date.

In March 2000, RTI made history in the allograft industry by developing its patented BioCleanse Sterilization Process. The BioCleanse Process is a low-temperature chemical sterilization process that inactivates or removes bacteria, fungi, spores and viruses from tissue without compromising the tissue’s biocompatibility or structural integrity.

In August 2000, RTI completed an initial public offering and began trading on the NASDAQ stock exchange under the symbol RTIX.

In August 2002, a US Patent for assembled bone implants was issued on August 6.

Acquisitions RTI was founded in February 1998 with a mission to reduce risk of contamination from allograft in orthopedic procedures, expanding into higher growth biologics markets via acquisitions of differentiated technologies. Pioneer was acquired in July 2013 by RTI Biologics, and the firm was then renamed RTI Surgical.

In February 2008, Regeneration Technologies merged with Tutogen, creating RTI Biologics, Inc. Both companies were in Progress Park in Alachua, Fla. Following the merger, RTI became one of the leading providers of sterile biologic implants for surgeries, offering surgeons both allograft and xenograft implants.

In July 2013, RTI acquired Marquette, Mich.-based Pioneer® Surgical Technology, Inc., a global manufacturer of metal and synthetic implants, becoming RTI Surgical. In July 2013, the acquisition resulted in an expanded product portfolio. Today, RTI continues to provide surgeons with safe biologic, metal and synthetic-based implants.

In January 2018, RTI signed an agreement to acquire Zyga Technology, Inc., a leading spine-focused medical device company that develops and produces innovative minimally invasive devices to treat underserved conditions of the lumbar spine. Zyga Technology’s primary product is the SImmetry® Sacroiliac Joint Fusion System.

In March 2019, RTI completed the acquisition of Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology. Paradigm Spine’s primary product is the coflex® Interlaminar Stabilization® device.

Honors and awards [edit source] •	RTI announced TETRAfuse® 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week. [5] •	In April 2018, RTI celebrated a significant global milestone of providing more than 8 million biologic implants processed through RTI’s proprietary sterilization processes with zero confirmed incidence of implant-associated infection. •	Orthopaedics News named it a "Top Company to Watch" in 2005. •	Michigan Governor Jennifer Granholm visited Pioneer in 2005 and cited Pioneer as an example of job creation in the Upper Peninsula.[4]

References [edit source] 1. ^ Benzel, Edward C. & Tator, Charles H. (2000). Contemporary Management of Spinal Cord Injuries: From Impact to Rehabilitation. Park Ridge, IL: American Association of Neurological Surgeons. p. 166. ISBN 978-1-879284-72-2. OCLC 247971013 – via Google Books. 2.	^ "Archived copy". Archived from the original on 2009-06-26. Retrieved 2007-11-13. 3.	^ "Pioneer Surgical Technology Acquires Nanotechnology Pioneer Angstrom Medica". Nanowerk. October 25, 2007. Retrieved June 18, 2018. 4.	^ Boyd, Liz (December 16, 2005). "Granholm Tours Pioneer Surgical Technology, Calls Company Example of Job Creation Package's Potential" (Press release). Archived from the original on December 17, 2009. 5.	^ Young, R. (October 15, 2018). Ten Best New Spine Technologies for 2018. Retrieved from https://ryortho.com/2018/10/ten-best-new-spine-technologies-for-2018/5/

RtixArchives (talk) 14:56, 12 June 2019 (UTC) JRumschlag

Not advertising
This page is clearly not spam as it doesn't even mention their current products by name. The article is modeled after similar companies, such as Medtronic. It is notable as the largest private employer in the U.P. and should not be deleted Marqmi 21:24, 13 November 2007 (UTC)
 * But is it the largest private employer in the UP? Doesn't Cliffs Mining Michigan, a subsidiary of Cleveland-Cliffs Iron Co. employ close to a thousand or more at the Empire and Tilden Mines in Richmond and Tilden townships, respectively? Imzadi1979 23:08, 15 November 2007 (UTC)
 * I do not know the number of employees at Cliffs Mining, but I do know it is a publicly-traded company, not a private one. Marqmi (talk) 21:04, 18 January 2008 (UTC)
 * But a public employer is a government, school district or state college. Cliff Mining-Michigan is still a private employer. --Imzadi1979 (talk) 21:10, 18 January 2008 (UTC)

Proposed updates Follow-up
I am the Corporate Archivist at RTI Surgical and want to follow-up regarding the previously proposed updates and clarifications to be made on our behalf to correct inaccuracies. Any assistance is welcome. RtixArchives (talk) 14:19, 14 August 2019 (UTC)

Edit request
I am the Corporate Archivist at RTI Surgical and propose the following updates and clarifications to be made on our behalf to correct inaccuracies. This is my first time engaging on Wikipedia. Any assistance is welcome.

RTI Surgical Company Overview RTI Surgical is a global surgical implant company that designs, develops, manufactures and distributes biologic, metal and synthetic implants. The company’s current focus is on investing in differentiated products and building scale in Spine and becoming a world-class private label OEM partner. RTI’s implants are used in spine, orthopedic, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.

RTI Surgical manufactures metal and synthetic implants and process donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using their proprietary BIOCLEANSE®, TUTOPLAST® and CANCELLE® SP sterilization processes. RTI processes tissue at facilities in Alachua, Florida, and Neunkirchen, Germany, and manufactures metal and synthetic implants in Marquette, Michigan and Greenville, North Carolina. They are a member of AdvaMed and accredited in the U.S. by the American Association of Tissue Banks. RTI Surgical implants are distributed directly to hospitals throughout the U.S. and in more than 50 countries worldwide with the support of both in-house and third-party representatives as well as through larger purchasing companies. RTI Surgical is a publicly traded company and is listed on Nasdaq under the symbol RTIX.

RTI Surgical’s spine portfolio includes hardware, interbody and orthobiologic products, including coflex, SImmetry, Fortilink IBF System with TETRAfuse and ViBone. Conditions that RTI Surgical products help treat range from lumbar spinal stenosis and sacroiliac joint pain to degenerative disc disease and a broad range of spinal disorders.

History In January 1969, The Tutoplast Tissue Sterilization Process was developed to sterilize and preserve tissue for implantation. The Tutoplast Process inactivates pathogens and removes bacteria, and the low dose gamma irradiation ensures sterility of the final packaged product.

In May 1992, Dr. Matthew Songer, an orthopedic surgeon, founded Pioneer in 1992 in Marquette, MI. Songer was not satisfied with the spinal cables on the market, which encouraged him to develop his own, a product we still distribute, called the Songer® Spinal Cable.

In October 1992, Tutogen Medical (Tutogen) formed and built its headquarters in Neunkirchen am Brand, Germany. Tutogen manufactured safe, high-quality xenograft and allograft implants for use in surgeries around the globe.

In January 1998, Tutogen expanded to the United States by moving its corporate headquarters to Progress Park in Alachua, Fla.

In February 1998, the University of Florida Tissue Bank transferred its allograft processing operations, related equipment and technologies, distribution arrangements, and research and development activities to Regeneration Technologies. This spin off from the University of Florida (UF) is one of the most successful UF technology transfers to date.

In March 2000, RTI made history in the allograft industry by developing its patented BioCleanse Sterilization Process. The BioCleanse Process is a low-temperature chemical sterilization process that inactivates or removes bacteria, fungi, spores and viruses from tissue without compromising the tissue’s biocompatibility or structural integrity.

In August 2000, RTI completed an initial public offering and began trading on the NASDAQ stock exchange under the symbol RTIX.

In August 2002, a US Patent for assembled bone implants was issued on August 6.

Acquisitions RTI was founded in February 1998 with a mission to reduce risk of contamination from allograft in orthopedic procedures, expanding into higher growth biologics markets via acquisitions of differentiated technologies. Pioneer was acquired in July 2013 by RTI Biologics, and the firm was then renamed RTI Surgical.

In February 2008, Regeneration Technologies merged with Tutogen, creating RTI Biologics, Inc. Both companies were in Progress Park in Alachua, Fla. Following the merger, RTI became one of the leading providers of sterile biologic implants for surgeries, offering surgeons both allograft and xenograft implants.

In July 2013, RTI acquired Marquette, Mich.-based Pioneer® Surgical Technology, Inc., a global manufacturer of metal and synthetic implants, becoming RTI Surgical. In July 2013, the acquisition resulted in an expanded product portfolio. Today, RTI continues to provide surgeons with safe biologic, metal and synthetic-based implants.

In January 2018, RTI signed an agreement to acquire Zyga Technology, Inc., a leading spine-focused medical device company that develops and produces innovative minimally invasive devices to treat underserved conditions of the lumbar spine. Zyga Technology’s primary product is the SImmetry® Sacroiliac Joint Fusion System.

In March 2019, RTI completed the acquisition of Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology. Paradigm Spine’s primary product is the coflex® Interlaminar Stabilization® device.

Honors and awards •	RTI announced TETRAfuse® 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week. •	In April 2018, RTI celebrated a significant global milestone of providing more than 8 million biologic implants processed through RTI’s proprietary sterilization processes with zero confirmed incidence of implant-associated infection. •	Orthopaedics News named it a "Top Company to Watch" in 2005. •	Michigan Governor Jennifer Granholm visited Pioneer in 2005 and cited Pioneer as an example of job creation in the Upper Peninsula.

References • Benzel, Edward C. & Tator, Charles H. (2000). Contemporary Management of Spinal Cord Injuries: From Impact to Rehabilitation. Park Ridge, IL: American Association of Neurological Surgeons. p. 166. ISBN 978-1-879284-72-2. OCLC 247971013 – via Google Books.

Young, R. (October 15, 2018). Ten Best New Spine Technologies for 2018. Retrieved from https://ryortho.com/2018/10/ten-best-new-spine-technologies-for-2018/5/

Boyd, Liz (December 16, 2005). "Granholm Tours Pioneer Surgical Technology, Calls Company Example of Job Creation Package's Potential" (Press release). Archived from the original on December 17, 2009.

RtixArchives (talk) 19:28, 3 September 2019 (UTC)

Reply 03-SEP-2019

 * Your edit request could not be reviewed because the claims made do not contain ref tags. When proposing edit requests, it's important to highlight in the text — through the use of ref tags — which specific sources are doing the referencing for each claim. The point of these ref tags is to allow the reviewer and reader to check that the material is sourced; that point will be lost if the references are not clearly placed.
 * In the collapsed section below titled Request edit examples, I have illustrated two: The first shows how the edit request was submitted; the second shows how requests should be submitted in the future.

 The Sun's diameter is 864,337 miles, while the Moon's diameter is 2,159 miles. The Sun's temperature is 5,778 Kelvin.

References

1. Sjöblad, Tristan. The Sun. Academic Press, 2019, p. 1. 2. Harinath, Paramjit. (2019). "Size of the Moon", Science, 51(78):46. 3. Uemura, Shū. The Sun's Heat. Academic Press, 2019, p. 2.

In the example above there are three references provided for the stated claims. But the text does not indicate which reference applies to which claim. Your edit request similarly does not provide ref tags indicating which source goes where. The links between material and their source references must be clearly made, as shown in the next example below:

 The Sun's diameter is 864,337 miles,[1] while the Moon's diameter is 2,159 miles.[2] The Sun's temperature is 5,778 Kelvin.[3]

References

^ Sjöblad, Tristan. The Sun. Academic Press, 2019, p. 1. ^ Harinath, Paramjit. (2019). "Size of the Moon", Science, 51(78):46. ^ Uemura, Shū. The Sun's Heat. Academic Press, 2019, p. 2.  In the example above the links between the provided references and their claim statements are perfectly clear. The use of ref tags has placed numbers within the text which indicate which reference goes where.


 * Kindly reformulate your edit request so that it aligns more with the second example above, and feel free to re-submit that edit request at your earliest convenience. Regards, Spintendo  23:42, 3 September 2019 (UTC)

Edit request
I am the Corporate Archivist at RTI Surgical and propose the following updates and clarifications to be made on our behalf to correct inaccuracies. This is my first time engaging on Wikipedia. Any assistance is welcome.

RTI Surgical Company Overview RTI Surgical is a global surgical implant company that designs, develops, manufactures and distributes biologic, metal and synthetic implants. The company’s current focus is on investing in differentiated products and building scale in Spine and becoming a world-class private label OEM partner. RTI’s implants are used in spine, orthopedic, sports medicine, general surgery, trauma and other surgical procedures to repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.

RTI Surgical manufactures metal and synthetic implants and process donated human musculoskeletal and other tissue and bovine and porcine animal tissue in producing allograft and xenograft implants using their proprietary BIOCLEANSE®, TUTOPLAST® and CANCELLE® SP sterilization processes. RTI processes tissue at facilities in Alachua, Florida, and Neunkirchen, Germany, and manufactures metal and synthetic implants in Marquette, Michigan and Greenville, North Carolina. They are a member of AdvaMed and accredited in the U.S. by the American Association of Tissue Banks. RTI Surgical implants are distributed directly to hospitals throughout the U.S. and in more than 50 countries worldwide with the support of both in-house and third-party representatives as well as through larger purchasing companies. RTI Surgical is a publicly traded company and is listed on Nasdaq under the symbol RTIX.

RTI Surgical’s spine portfolio includes hardware, interbody and orthobiologic products, including coflex, SImmetry, Fortilink IBF System with TETRAfuse and ViBone. Conditions that RTI Surgical products help treat range from lumbar spinal stenosis and sacroiliac joint pain to degenerative disc disease and a broad range of spinal disorders.

History In January 1969, The Tutoplast Tissue Sterilization Process was developed to sterilize and preserve tissue for implantation. The Tutoplast Process inactivates pathogens and removes bacteria, and the low dose gamma irradiation ensures sterility of the final packaged product.

In May 1992, Dr. Matthew Songer, an orthopedic surgeon, founded Pioneer in 1992 in Marquette, MI. Songer was not satisfied with the spinal cables on the market, which encouraged him to develop his own, a product we still distribute, called the Songer® Spinal Cable.

In October 1992, Tutogen Medical (Tutogen) formed and built its headquarters in Neunkirchen am Brand, Germany. Tutogen manufactured safe, high-quality xenograft and allograft implants for use in surgeries around the globe.

In January 1998, Tutogen expanded to the United States by moving its corporate headquarters to Progress Park in Alachua, Fla.

In February 1998, the University of Florida Tissue Bank transferred its allograft processing operations, related equipment and technologies, distribution arrangements, and research and development activities to Regeneration Technologies. This spin off from the University of Florida (UF) is one of the most successful UF technology transfers to date.

In March 2000, RTI made history in the allograft industry by developing its patented BioCleanse Sterilization Process. The BioCleanse Process is a low-temperature chemical sterilization process that inactivates or removes bacteria, fungi, spores and viruses from tissue without compromising the tissue’s biocompatibility or structural integrity.

In August 2000, RTI completed an initial public offering and began trading on the NASDAQ stock exchange under the symbol RTIX.

In August 2002, a US Patent for assembled bone implants was issued on August 6.

Acquisitions RTI was founded in February 1998 with a mission to reduce risk of contamination from allograft in orthopedic procedures, expanding into higher growth biologics markets via acquisitions of differentiated technologies. Pioneer was acquired in July 2013 by RTI Biologics, and the firm was then renamed RTI Surgical.

In February 2008, Regeneration Technologies merged with Tutogen, creating RTI Biologics, Inc. Both companies were in Progress Park in Alachua, Fla. Following the merger, RTI became one of the leading providers of sterile biologic implants for surgeries, offering surgeons both allograft and xenograft implants.

In July 2013, RTI acquired Marquette, Mich.-based Pioneer® Surgical Technology, Inc., a global manufacturer of metal and synthetic implants, becoming RTI Surgical. In July 2013, the acquisition resulted in an expanded product portfolio. Today, RTI continues to provide surgeons with safe biologic, metal and synthetic-based implants.

In January 2018, RTI signed an agreement to acquire Zyga Technology, Inc., a leading spine-focused medical device company that develops and produces innovative minimally invasive devices to treat underserved conditions of the lumbar spine. Zyga Technology’s primary product is the SImmetry® Sacroiliac Joint Fusion System.

In March 2019, RTI completed the acquisition of Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology. Paradigm Spine’s primary product is the coflex® Interlaminar Stabilization® device.

Honors and awards • RTI announced TETRAfuse® 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week. • In April 2018, RTI celebrated a significant global milestone of providing more than 8 million biologic implants processed through RTI’s proprietary sterilization processes with zero confirmed incidence of implant-associated infection. • Orthopaedics News named it a "Top Company to Watch" in 2005. • Michigan Governor Jennifer Granholm visited Pioneer in 2005 and cited Pioneer as an example of job creation in the Upper Peninsula.

RtixArchives (talk) 20:27, 25 November 2019 (UTC)

Reply 25-NOV-2019
Regards, Spintendo  23:17, 25 November 2019 (UTC)
 * Large portions of the proposed text are unreferenced. Please note that articles should not contain multiple paragraphs of text without any references. Sources should be provided for every major constituent claim made within the article.